A drug which is said to "reboot" the immune system has been shown to be an effective treatment for multiple sclerosis (MS), a study has found.
The results of the trials were so encouraging in reducing the number of attacks in those affected that the MS Society is campaigning for the drug to become available on the NHS.
The research showed that alemtuzumab significantly reduced the number of attacks or relapses by people with MS compared to the current drug interferon beta-1a which is known commercially as Rebif.
More top news
The Tonight programme looks at government efforts to improve our general wellbeing, and offers tips on how we can all boost our happiness.
While writing The Great Fire, I was interested to find striking parallels between Britain in 1666 and modern-day equivalents.
Tory Chief Whip Michael Gove has taken time out from his schedule to claim second place in Westminster's Dog of the Year competition.